Core Scientific (CORZ) Free Cash Flow (2021 - 2026)

Core Scientific has disclosed Free Cash Flow across 6 years of filings, most recently posting -$139.3 million for Q1 2026.

• Free Cash Flow for Q1 2026 came in at -$139.3 million, down 8.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$461.1 million (down 126.93% YoY), and the FY2025 annual result was -$450.8 million, down 765.74% from the prior year.
• Free Cash Flow came in at -$139.3 million for Q1 2026 at Core Scientific, down from -$121.7 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $178.3 million in Q4 2022 to a low of -$139.3 million in Q1 2026.
• The 5-year median for Free Cash Flow is -$26.1 million (2022), against an average of -$33.5 million.
• Across the five-year window, Free Cash Flow jumped 170.44% in 2023 and plunged 7656.62% in 2025, its largest moves.
• Core Scientific's Free Cash Flow stood at $178.3 million in 2022, then plunged by 94.36% to $10.1 million in 2023, then slumped by 248.67% to -$15.0 million in 2024, then sank by 714.14% to -$121.7 million in 2025, then declined by 14.47% to -$139.3 million in 2026.
• The last three Free Cash Flow figures came in at -$139.3 million (Q1 2026), -$121.7 million (Q4 2025), and -$112.7 million (Q3 2025), per Business Quant data.